{
  "paper_metadata": {
    "pmid": "37014422",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 20,
        "demographics": "Mean age 64.1 \u00b1 2.9 years, 15 male, 5 female",
        "phenotype": "ATTRv amyloidosis (6 ATTRv-CM, 14 ATTRv-PN)"
      },
      "penetrance_data": {
        "total_carriers_observed": 20,
        "affected_count": 15,
        "unaffected_count": 5,
        "uncertain_count": null,
        "penetrance_percentage": 75.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 64,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "ATTRv-CM",
          "evidence_sentence": "Six patients were classified as ATTRv-CM patients (3 male, 3 female, mean age 67.7 \u00b1 5.8 years)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 62,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "ATTRv-PN",
          "evidence_sentence": "14 as ATTRv-PN patients (12 male, 2 female, mean age 62.9 \u00b1 3.1 years)."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "presymptomatic carrier",
          "evidence_sentence": "5 presymptomatic carriers (2 male, 3 female, mean age 40.4 \u00b1 2.8 years)."
        }
      ],
      "functional_data": {
        "summary": "CCM identifies small nerve fibre damage in presymptomatic carriers and symptomatic patients.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the genetic heterogeneity and clinical variability of TTR mutations.",
      "key_quotes": [
        "To date, more than 120 amyloidogenic mutations of the TTR gene have been identified.",
        "Age at disease onset ranges from 20 to 80 years, and penetrance is incomplete."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Characteristics of patients with ATTRv amyloidosis and presymptomatic carriers",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for the TTR gene was extracted successfully."
  }
}